|
|
Last Modified: 11/22/2005 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
premenopausal
|
|
|
|
|
|
|
|
FRE-FNCLCC-9456 NCI-F94-0023
|
|
|
|
|
|
|
|
Last Modified: 7/6/2007  First Published: 7/1/1997 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
Any age
|
|
|
|
Other
|
|
|
|
EORTC-22961 EORTC-GU-22961, NCT00003026
|
|
|
|
|
|
|
|
Last Modified: 5/31/2007  First Published: 3/1/1999 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
18 and over
|
|
|
|
Other
|
|
|
|
ICORG-97-01 EU-98060, NCT00003734
|
|
|
|
|
|
|
|
Last Modified: 10/23/2008  First Published: 7/26/2003 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Treatment
|
|
|
|
Completed
|
|
|
|
Premenopausal
|
|
|
|
NCI
|
|
|
|
IBCSG-26-02 BIG-4-02, NABCI-IBCSG-26-02, EU-20401, NCT00066807, EUDRACT-2005-002626-59
|
|
|
|
|
|
|
|
Last Modified: 4/16/2008  First Published: 3/27/2006 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Biomarker/Laboratory analysis, Supportive care, Treatment
|
|
|
|
Completed
|
|
|
|
18 to 45
|
|
|
|
Other
|
|
|
|
GIM-6 GIM-PROMISE, EU-20606, GIM-5104, NCT00311636
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
18 and over
|
|
|
|
|
|
|
|
EORTC-55876
|
|
|
|
|
|
|
|
Last Modified: 6/6/2008  First Published: 8/24/2004 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II
|
|
|
|
Supportive care
|
|
|
|
Completed
|
|
|
|
Under 45
|
|
|
|
NCI
|
|
|
|
MCC-0203 NCI-7031, NCT00090844, 7031, HLMCC 0203
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II
|
|
|
|
Treatment
|
|
|
|
Temporarily closed
|
|
|
|
18 and over
|
|
|
|
Pharmaceutical / Industry
|
|
|
|
I-48-52014-142 NCT00444639
|
|
|
|